newsfilter
← Latest News
Business Wire·

GoodRx Reports First Quarter 2026 Results

Pharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us,"